The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments

Related articles

eBlogs

06
14
24

Characterization is key: how to evaluate mRNA therapeutic safety and efficacy

Before release into the clinic mRNA therapeutics need comprehensive characterization. In this eBlog we review several key aspects to profile before release...[READ MORE]

read more

eBlogs

04
30
24

RNA therapeutics: a review of the future of medicine

RNA therapeutics have revolutionized medicine. In this eBlog we discuss the different types of RNA therapeutics that have received FDA approval...[READ MORE]

read more

eBlogs

04
11
24

Discovering miRNA regulation with miR-eCLIP

miRNAs are key regulators of expression and translation, however identifying where and how they bind can be a challenge. In this eBlog we reveal how miR-eCLIP can be used to directly profile miRNA activity...[READ MORE]

read more

eBlogs

02
26
24

Successful mRNA therapeutic design: optimizing for stability and translation

mRNA therapeutics have unlocked the potential for rapid responses to infectious disease, personalized treatments for cancer, and protein replacement for different diseases. To ensure efficacy, specific features need to be included in the therapeutic to promote stability, efficient translation, and to... [READ MORE]

read more